Ann: Mayne Pharma presentation at JP Morgan Healthcare Conference, page-24

First 24 Last

Share
Profile

Follow
rogerthedog

378 Posts.

229

15/01/24

09:22

Post #: 71876983
Share

Originally posted by stephencca: ↑

Re my comments on other contributors to this forum. For years I have listened to incessant ravings etc etc about all the previous board. It was a waste of air and time. They appear to have gone quiet.

As you agree, nearly everything was set up by the previous management - even bad "management" can have some good ideas.
Without NEXTSTELLIS MYX wouldnt have the first class portfolio and wouldnt be able to attract other items to themselves due to eventual size.
Paying a price for a novel product can always be criticised. We will see in 2 years if it was a high price. Its novel, there is no competition, it could become a billion dollar income.

People can criticise the money spent on launching the product BUT they never put forward any other method of launching. Remember the products they just bought had a very high 2 year launch cost - and it was (probably) one of the reasons the company didnt survive. MYX didnt buy the company when they first looked at it. They walked away and later just took the products that were left when it fell over. Nobody else took the product - probably because the launch and support costs are so great.

The new management have tried a few things and walked back on some ie direct to consumer, because there is insufficient product being sold.
They have also cancelled 6 sale areas BUT have maintained the rest of the 50 odd areas. This means they are affirming the previous decisions. Current management also said in todays presentation that other suppliers of competitive drugs etc have been withdrawing due to the costs. Does anyone know of any other system of distribution like that being implemented by MYX ie from Dr to Pharmacy to Patient.

This is the magic of having so many good/great products to market in both target areas.

YET THE SHARE PRICE HAS GONE DOWN.... Perhaps people need time to understand.

Expand

You need to drink less of your own Kool Aid. What capital loss are you sitting on at the moment for MYX?
The criticisms of the previous board and management were, and still are, valid given that they nearly drove this company into bankruptcy.
While there are positive signs, we're currently sitting somewhere near only 30 cents per share in the old pre consolidation terms. Disappointing in terms of share price but probably valid given that we're still a long way from the riches you seem to think are imminent.

MYX Price at posting: $5.46 Sentiment: Sell Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

SI6

Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin jumps 8% to beat record on Trump vote optimism

LRD

Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62%

First 24 Last

Add MYX (ASX) to my watchlist

(20min delay)
Last $4.42		Change 0.160(3.76%)		Mkt cap ! $376.0M

Open	High	Low	Value	Volume
$4.29	$4.42	$4.21	$552.0K	127.8K

Buyers (Bids)

No.	Vol.	Price($)
1	1366	$4.38

Sellers (Offers)

Price($)	Vol.	No.
$4.43	661	1

View Market Depth

No.	Vol.	Price($)
1	1366	4.380
1	661	4.360
1	661	4.350
1	661	4.340
1	1200	4.280

Price($)	Vol.	No.
4.430	661	1
4.440	661	1
4.450	661	1
4.470	1200	1
4.480	2917	2

Last trade - 16.10pm 06/11/2024 (20 minute delay)

MYX (ASX) Chart

Ann: Mayne Pharma presentation at JP Morgan Healthcare Conference, page-24

Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin jumps 8% to beat record on Trump vote optimism

Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Mayne Pharma presentation at JP Morgan Healthcare Conference, page-24

Top Stories

Nanocap Si6 Metals to kick off drilling at Monument gold project WA, chasing past hits

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Bitcoin jumps 8% to beat record on Trump vote optimism

Lord picks up high-grade copper play in Western Australia, with past intercepts of up to 6.62%

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News